Skip to main content
Top
Published in: Infection 5/2019

01-10-2019 | Leishmania | Original Paper

Asymptomatic Leishmania infection in blood donors from the Southern of Spain

Authors: Luis Aliaga, Julián Ceballos, Antonio Sampedro, Fernando Cobo, Miguel Ángel López-Nevot, Gemma Merino-Espinosa, Francisco Morillas-Márquez, Joaquina Martín-Sánchez

Published in: Infection | Issue 5/2019

Login to get access

Abstract

Objectives

To investigate the proportion of asymptomatic infection among blood donors in a region endemic for Leishmania; and to ascertain epidemiological and genetic factors associated with this condition.

Methods

We studied 1260 blood donors in the Province of Granada in the Southern Spain. After obtaining informed consent in each participant, a poll about habits, housing and contact with animals were carried out. Blood samples were obtained for determining antileishmanial antibodies and a PCR assay. HLA typing was performed in a randomly sample among the donors with positive serology.

Results

We have found that L. infantum antibodies were present in 7.9% of blood donors and DNA in blood was detected in 2.5% of donors. There was no concordance between both determinations, except in one patient. Taking into consideration both techniques, 129 participants were considered to have asymptomatic Leishmania infection. No participant in this study developed clinical leishmaniasis during a follow-up period of 2 years. HLA were typed in 51 donors. Asymptomatic Leishmania infection might be associated with certain HLA antigens. A multivariate analysis was done with the variables obtained through the participants’ interview. The contact with livestock (goats, pigs, and sheep), but not dogs, either at home or in the environment, was significantly and independently associated with asymptomatic leishmania infection.

Conclusions

Asymptomatic leishmanial infection among blood donors is frequent in the Granada Province, south of Spain. The presence of livestock in this region is related to this infection, perhaps influencing vector density of this disease. Some HLA genes might be associated with asymptomatic leishmanial state.
Literature
1.
go back to reference Ready PD. Leishmaniasis emergence in Europe. Euro Surveill. 2010;15:19505.PubMed Ready PD. Leishmaniasis emergence in Europe. Euro Surveill. 2010;15:19505.PubMed
3.
go back to reference Magill AJ. Leishmania species: visceral (Kala-Azar), cutaneous, and mucosal leishmaniasis. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier/Saunders; 2015. p. 3091–107.e4. Magill AJ. Leishmania species: visceral (Kala-Azar), cutaneous, and mucosal leishmaniasis. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier/Saunders; 2015. p. 3091–107.e4.
4.
go back to reference Murray HW, Berman HD, Saravia NG. Advances in leishmaniasis. Lancet. 2005;366:1561–77.CrossRef Murray HW, Berman HD, Saravia NG. Advances in leishmaniasis. Lancet. 2005;366:1561–77.CrossRef
5.
go back to reference Le Fichoux Y, Quaranta JF, Aufeuvre JP, Lelievre A, Marty P, Suffia I, et al. Occurrence of Leishmania infantum cryptic parasitemia in asymptomatic blood donors living in an area of endemicity in Southern France. J Clin Microbiol. 1999;37:1953–7.PubMedPubMedCentral Le Fichoux Y, Quaranta JF, Aufeuvre JP, Lelievre A, Marty P, Suffia I, et al. Occurrence of Leishmania infantum cryptic parasitemia in asymptomatic blood donors living in an area of endemicity in Southern France. J Clin Microbiol. 1999;37:1953–7.PubMedPubMedCentral
6.
go back to reference Riera C, Fisa R, Udina M, Gallego M, Portus M. Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area (Eivissa, Balearic Islands, Spain) by different diagnostic methods. Trans R Soc Trop Med Hyg. 2004;98:102–10.CrossRef Riera C, Fisa R, Udina M, Gallego M, Portus M. Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area (Eivissa, Balearic Islands, Spain) by different diagnostic methods. Trans R Soc Trop Med Hyg. 2004;98:102–10.CrossRef
7.
go back to reference Riera C, Fisa R, López-Chejade P, Serra T, Girona E, Jiménez T, et al. Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain). Transfusion. 2008;48:1383–9.CrossRef Riera C, Fisa R, López-Chejade P, Serra T, Girona E, Jiménez T, et al. Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain). Transfusion. 2008;48:1383–9.CrossRef
8.
go back to reference Pérez-Cutillas P, Goyena E, Chitimia L, De la Rúa P, Bernal LJ, Fisa R, et al. Spatial distribution of human asymptomatic Leishmania infantum infection in southeast Spain: a study of environmental, demographic and social risk factors. Acta Trop. 2015;146:127–34.CrossRef Pérez-Cutillas P, Goyena E, Chitimia L, De la Rúa P, Bernal LJ, Fisa R, et al. Spatial distribution of human asymptomatic Leishmania infantum infection in southeast Spain: a study of environmental, demographic and social risk factors. Acta Trop. 2015;146:127–34.CrossRef
9.
go back to reference Jimenez-Marco T, Riera C, Girona-Llobera E, Guillen C, Iniesta L, Alcover M, et al. Strategies for reducing the risk of transfusion-transmitted leishmaniasis in an area endemic for Leishmania infantum: a patient- and donor-targeted approach. Blood Transfus. 2018;16:130–6.PubMedPubMedCentral Jimenez-Marco T, Riera C, Girona-Llobera E, Guillen C, Iniesta L, Alcover M, et al. Strategies for reducing the risk of transfusion-transmitted leishmaniasis in an area endemic for Leishmania infantum: a patient- and donor-targeted approach. Blood Transfus. 2018;16:130–6.PubMedPubMedCentral
10.
go back to reference Singh OP, Hasker E, Sacks D, Boelaert M, Sundar S. Asymptomatic Leishmania infection: A new challenge for Leishmania control. Clin Infect Dis. 2014;58:1424–9.CrossRef Singh OP, Hasker E, Sacks D, Boelaert M, Sundar S. Asymptomatic Leishmania infection: A new challenge for Leishmania control. Clin Infect Dis. 2014;58:1424–9.CrossRef
11.
go back to reference Merino-Espinosa G, Corpas-López V, Díaz-Sáez V, Morillas-Márquez F, Tercedor-Sánchez J, Azaña-Defez JM, et al. Cutaneous leishmaniasis by Leishmania infantum: behind granulomatous lesions of unknown aetiology. J Eur Acad Dermatol Venereol. 2018;32:117–24.CrossRef Merino-Espinosa G, Corpas-López V, Díaz-Sáez V, Morillas-Márquez F, Tercedor-Sánchez J, Azaña-Defez JM, et al. Cutaneous leishmaniasis by Leishmania infantum: behind granulomatous lesions of unknown aetiology. J Eur Acad Dermatol Venereol. 2018;32:117–24.CrossRef
12.
go back to reference Martín-Sánchez J, López-López MC, Acedo-Sánchez C, Castro-Fajardo JJ, Pineda JA, Morillas-Márquez F. Diagnosis of infections with Leishmania infantum using PCR-ELISA. Parasitology. 2001;122:607–15.CrossRef Martín-Sánchez J, López-López MC, Acedo-Sánchez C, Castro-Fajardo JJ, Pineda JA, Morillas-Márquez F. Diagnosis of infections with Leishmania infantum using PCR-ELISA. Parasitology. 2001;122:607–15.CrossRef
13.
go back to reference França AdO, Pompilio MA, Pontes ERJC, De Oliveira MP, Pereira LOR, Lima RB, et al. Leishmania infection in blood donors: a new challenge in leishmaniasis transmission? PLoS One. 2018;13:e0198199.CrossRef França AdO, Pompilio MA, Pontes ERJC, De Oliveira MP, Pereira LOR, Lima RB, et al. Leishmania infection in blood donors: a new challenge in leishmaniasis transmission? PLoS One. 2018;13:e0198199.CrossRef
14.
go back to reference Martín-Sánchez J, Pineda JA, Morillas-Márquez F, García-García JA, Acedo C, Macías J. Detection of Leishmania infantum kinetoplast DNA in peripheral blood from asymptomatic individuals at risk for parenterally transmitted infections: relationship between polymerase chain reaction results and other Leishmania infection markers. Am J Trop Med Hyg. 2004;70:545–8.CrossRef Martín-Sánchez J, Pineda JA, Morillas-Márquez F, García-García JA, Acedo C, Macías J. Detection of Leishmania infantum kinetoplast DNA in peripheral blood from asymptomatic individuals at risk for parenterally transmitted infections: relationship between polymerase chain reaction results and other Leishmania infection markers. Am J Trop Med Hyg. 2004;70:545–8.CrossRef
15.
go back to reference Elmahallawy EK, Cuadros-Moronta E, Liébana-Martos MC, Rodríguez-Granger J, Sampedro-Martínez A, Agil A, et al. Seroprevalence of Leishmania infection among asymptomatic renal transplant recipients from southern Spain. Transpl Infect Dis. 2015;17:795–9.CrossRef Elmahallawy EK, Cuadros-Moronta E, Liébana-Martos MC, Rodríguez-Granger J, Sampedro-Martínez A, Agil A, et al. Seroprevalence of Leishmania infection among asymptomatic renal transplant recipients from southern Spain. Transpl Infect Dis. 2015;17:795–9.CrossRef
16.
go back to reference Moreno EC, Gonçalves AV, Chaves AV, Melo MN, Lambertucci JR, Andrade ASR, et al. Inaccuracy of enzyme-linked immunosorbent assay using soluble and recombinant antigens to detect asymptomatic infection by Leishmania infantum. PLoS Negl Trop Dis. 2009;3:e536.CrossRef Moreno EC, Gonçalves AV, Chaves AV, Melo MN, Lambertucci JR, Andrade ASR, et al. Inaccuracy of enzyme-linked immunosorbent assay using soluble and recombinant antigens to detect asymptomatic infection by Leishmania infantum. PLoS Negl Trop Dis. 2009;3:e536.CrossRef
17.
go back to reference Michel G, Pomares C, Ferrua B, Marty P. Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human. Acta Trop. 2011;119:69–75.CrossRef Michel G, Pomares C, Ferrua B, Marty P. Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human. Acta Trop. 2011;119:69–75.CrossRef
18.
go back to reference Maritati M, Trentini A, Michel G, Bellini T, Almugadam S, Hanau S, et al. Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs. Infection. 2018;46:801–9.CrossRef Maritati M, Trentini A, Michel G, Bellini T, Almugadam S, Hanau S, et al. Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs. Infection. 2018;46:801–9.CrossRef
19.
go back to reference Jiménez-Marco T, Fisa R, Girona-Llobera E, Cancino-Faure B, Tomás-Pérez M, Berenguer D, et al. Transfusion-transmitted leishmaniasis: a practical review. Transfusion. 2016;56:45–51.CrossRef Jiménez-Marco T, Fisa R, Girona-Llobera E, Cancino-Faure B, Tomás-Pérez M, Berenguer D, et al. Transfusion-transmitted leishmaniasis: a practical review. Transfusion. 2016;56:45–51.CrossRef
20.
go back to reference Singh T, Fakiola M, Oomen J, Singh AP, Singh AK, Smith N, et al. Epitope-binding characteristics for risk versus protective DRB1 alleles for visceral leishmaniasis. J Immunol. 2018;200:2727–37.CrossRef Singh T, Fakiola M, Oomen J, Singh AP, Singh AK, Smith N, et al. Epitope-binding characteristics for risk versus protective DRB1 alleles for visceral leishmaniasis. J Immunol. 2018;200:2727–37.CrossRef
21.
go back to reference Fakiola M, Strange A, Cordell HJ, Miller EN, Pirinen M, Su Z, et al. Common variants in the HLA-DRB1-HLA-DQA1 class II region are associated with susceptibility to visceral leishmaniasis. Nat Genet. 2013;45:208–13.CrossRef Fakiola M, Strange A, Cordell HJ, Miller EN, Pirinen M, Su Z, et al. Common variants in the HLA-DRB1-HLA-DQA1 class II region are associated with susceptibility to visceral leishmaniasis. Nat Genet. 2013;45:208–13.CrossRef
22.
go back to reference Bern C, Joshi AB, Jha SN, Das ML, Hightower A, Thakur GD, et al. Factors associated with visceral leishmaniasis in Nepal: bed-net use is strongly protective. Am J Trop Med Hyg. 2000;63:184–8.CrossRef Bern C, Joshi AB, Jha SN, Das ML, Hightower A, Thakur GD, et al. Factors associated with visceral leishmaniasis in Nepal: bed-net use is strongly protective. Am J Trop Med Hyg. 2000;63:184–8.CrossRef
23.
go back to reference Barnett PG, Singh SP, Bern C, Hightower AW, Sundar S. Virgin soil: the spread of visceral leishmaniasis into Uttar Pradesh, India. Am J Trop Med Hyg. 2005;73:720–5.CrossRef Barnett PG, Singh SP, Bern C, Hightower AW, Sundar S. Virgin soil: the spread of visceral leishmaniasis into Uttar Pradesh, India. Am J Trop Med Hyg. 2005;73:720–5.CrossRef
24.
go back to reference Bern C, Haque R, Chowdhury R, Ali M, Kurkjiam DM, Vaz L. et. al. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village. Am J Trop Med Hyg. 2007;76:129–32.CrossRef Bern C, Haque R, Chowdhury R, Ali M, Kurkjiam DM, Vaz L. et. al. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village. Am J Trop Med Hyg. 2007;76:129–32.CrossRef
25.
26.
go back to reference Jacobson RL. Leishmania tropica (Kinetoplastida: Trypanosomatidae)—a perplexing parasite. Folia Parasitol (Praha). 2003;50:241–50.CrossRef Jacobson RL. Leishmania tropica (Kinetoplastida: Trypanosomatidae)—a perplexing parasite. Folia Parasitol (Praha). 2003;50:241–50.CrossRef
Metadata
Title
Asymptomatic Leishmania infection in blood donors from the Southern of Spain
Authors
Luis Aliaga
Julián Ceballos
Antonio Sampedro
Fernando Cobo
Miguel Ángel López-Nevot
Gemma Merino-Espinosa
Francisco Morillas-Márquez
Joaquina Martín-Sánchez
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2019
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-019-01297-3

Other articles of this Issue 5/2019

Infection 5/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.